Document is current

Any future updates will be listed below

498 Preclinical characterization of OR502, an anti-LILRB2 antibody that rescues innate and adaptive immune responses from LILRB2 mediated immune suppression

Crossref DOI link: https://doi.org/10.1136/jitc-2022-SITC2022.0498

Published Online: 2022-11-07

Published Print: 2022-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark